0,932  0,003  Antihypercholesterolemic
0,914  0,004  TNF expression inhibitor
0,898  0,004  Antioxidant
0,877  0,004  Lipoxygenase inhibitor
0,872  0,004  Radioprotector
0,858  0,003  AR expression inhibitor
0,856  0,009  Antiinflammatory
0,851  0,010  Transcription factor NF kappa B inhibitor
0,839  0,003  NOS2 expression inhibitor
0,836  0,012  Apoptosis agonist
0,823  0,004  Chemopreventive
0,769  0,002  Lipid peroxidase inhibitor
0,762  0,004  UGT1A9 substrate
0,763  0,012  Antineoplastic (lung cancer)
0,760  0,013  Antineoplastic (breast cancer)
0,739  0,004  Skin whitener
0,741  0,009  Carcinogenic
0,728  0,005  Spasmolytic
0,729  0,006  CYP2C19 substrate
0,712  0,005  Antineoplastic (glioma)
0,712  0,005  Free radical scavenger
0,705  0,004  Antineoplastic (multiple myeloma)
0,696  0,004  Monophenol monooxygenase inhibitor
0,670  0,006  Antiischemic
0,658  0,002  Neurotrophic factor enhancer
0,664  0,012  Prostate cancer treatment
0,661  0,012  Chemoprotective
0,655  0,007  Lipoprotein disorders treatment
0,653  0,008  Proliferative diseases treatment
0,643  0,005  Antiprotozoal (Leishmania)
0,644  0,007  Cardioprotectant
0,635  0,010  Antineoplastic (melanoma)
0,627  0,009  Caspase 3 stimulant
0,622  0,005  Antineoplastic (glioblastoma multiforme)
0,626  0,013  Antineoplastic (ovarian cancer)
0,613  0,001  Cholesterol synthesis inhibitor
0,613  0,005  Antineoplastic (renal cancer)
0,610  0,006  Hypolipemic
0,595  0,009  Antineoplastic (brain cancer)
0,607  0,023  Antileukemic
0,584  0,015  Stroke treatment
0,570  0,003  Antifungal enhancer
0,570  0,005  Antiulcerative
0,561  0,006  Wound healing agent
0,558  0,014  Antiosteoporotic
0,553  0,011  Hypoglycemic
0,571  0,029  Alzheimer's disease treatment
0,546  0,008  Antihypertriglyceridemic
0,541  0,005  Melanin inhibitor
0,545  0,013  Nitric oxide antagonist
0,558  0,031  15-Lipoxygenase inhibitor
0,522  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,540  0,019  Cytotoxic
0,521  0,009  ICAM1 expression inhibitor
0,531  0,022  Bone diseases treatment
0,510  0,005  NOS3 expression enhancer
0,510  0,010  Antidiabetic symptomatic
0,500  0,009  Antineoplastic (lymphocytic leukemia)
0,521  0,035  Antibacterial
0,487  0,011  Acute neurologic disorders treatment
0,478  0,004  Electron transport complex I inhibitor
0,482  0,011  Peroxidase inhibitor
0,509  0,048  Antidiabetic
0,509  0,048  Cyclophilin D inhibitor
0,477  0,020  Antineoplastic (non-small cell lung cancer)
0,486  0,035  Cholesterol antagonist
0,481  0,032  Antithrombotic
0,475  0,029  CYP2D6 substrate
0,452  0,010  Myocardial ischemia treatment
0,457  0,015  Vasodilator
0,480  0,039  Antineoplastic (colorectal cancer)
0,449  0,009  Abortion inducer
0,472  0,037  Antineoplastic (colon cancer)
0,461  0,029  Antifungal
0,455  0,027  Apoptosis antagonist
0,453  0,028  CTGF expression inhibitor
0,455  0,030  Hepatic disorders treatment
0,439  0,021  Antiprotozoal (Trypanosoma)
0,431  0,014  UGT1A1 substrate
0,437  0,021  Antiglaucomic
0,417  0,010  Antineoplastic (squamous cell carcinoma)
0,445  0,042  Vasodilator, peripheral
0,415  0,022  UGT1A6 substrate
0,404  0,011  UGT2B7 substrate
0,425  0,032  Antineoplastic (pancreatic cancer)
0,398  0,008  Protein kinase stimulant
0,412  0,027  Hypoxia-inducible factor 1 alpha inhibitor
0,387  0,004  TRPA1 agonist
0,384  0,004  Farnesoid X receptor antagonist
0,394  0,013  Antianginal
0,435  0,055  Antiprotozoal
0,384  0,005  5-Lipoxygenase inhibitor
0,436  0,057  Histamine release inhibitor
0,426  0,054  Immunosuppressant
0,393  0,024  Myocardial infarction treatment
0,387  0,019  RNA-directed DNA polymerase inhibitor
0,364  0,004  Prostaglandin-E synthase inhibitor
0,398  0,039  NOS3 expression inhibitor
0,444  0,086  Caspase 9 stimulant
0,384  0,039  Antineoplastic (cervical cancer)
0,367  0,024  Antineoplastic enhancer
0,354  0,018  Hepatoprotectant
0,355  0,020  P-glycoprotein inhibitor
0,347  0,017  Thrombolytic
0,357  0,032  Antiparasitic
0,358  0,035  Mutagenic
0,362  0,040  Sensitization
0,327  0,006  Dementia treatment
0,325  0,005  Vascular dementia treatment
0,358  0,040  Huntington's disease treatment
0,324  0,007  Neurotrophic factor
0,339  0,022  Platelet adhesion inhibitor
0,340  0,024  Antihelmintic
0,319  0,004  Pregnane X receptor agonist
0,320  0,010  NADPH oxidase inhibitor
0,324  0,015  Genotoxic
0,359  0,062  Immunostimulant
0,327  0,030  UDP-glucuronosyltransferase substrate
0,295  0,003  Maillard reaction inhibitor
0,368  0,079  GST A substrate
0,331  0,043  Platelet antagonist
0,288  0,004  TRPA1 antagonist
0,392  0,110  Antineoplastic (solid tumors)
0,306  0,024  VCAM1 expression inhibitor
0,358  0,078  CYP2C9 substrate
0,372  0,092  Antiparkinsonian
0,324  0,047  Cytostatic
0,288  0,013  Antihyperlipoproteinemic
0,335  0,062  Antimycobacterial
0,287  0,015  Phospholipase A2 inhibitor
0,317  0,046  Cardiovascular analeptic
0,282  0,011  LDLR expression enhancer
0,301  0,033  Antiviral (HIV)
0,346  0,079  CYP3A4 substrate
0,312  0,047  Antineoplastic (lymphoma)
0,265  0,005  Hearing loss treatment
0,316  0,056  Antidiabetic (type 2)
0,271  0,011  Antihemorrhagic
0,282  0,023  Protein-tyrosine phosphatase inhibitor
0,271  0,013  Protein-tyrosine phosphatase 1B inhibitor
0,259  0,003  Peroxisome proliferator-activated receptor alpha agonist
0,330  0,076  Antiallergic
0,310  0,057  UGT2B4 substrate
0,251  0,005  Arachidonic acid antagonist
0,282  0,037  Antihypotensive
0,305  0,064  Antituberculosic
0,266  0,026  Skin irritative effect
0,266  0,027  Antiacne
0,336  0,098  Atherosclerosis treatment
0,291  0,054  GST M1-1 substrate
0,239  0,004  Bile acid receptor antagonist
0,246  0,011  Alcohol dehydrogenase substrate
0,240  0,006  Vanilloid 1 agonist
0,292  0,059  Amyotrophic lateral sclerosis treatment
0,233  0,004  Antiviral (Coronavirus)
0,233  0,004  Antiviral (SARS coronavirus)
0,282  0,061  Tumour necrosis factor alpha release inhibitor
0,251  0,030  Antineoplastic (carcinoma)
0,251  0,031  Growth factor agonist
0,242  0,023  Cyclooxygenase 1 inhibitor
0,225  0,007  Estrogen receptor alpha antagonist
0,223  0,005  Peroxisome proliferator-activated receptor gamma agonist
0,218  0,005  Lipase inhibitor
0,277  0,065  Embryotoxic
0,210  0,006  Vanilloid agonist
0,214  0,012  Coagulant
0,210  0,010  Gastric antisecretory
0,228  0,035  Amylase inhibitor
0,309  0,118  CYP2C19 inhibitor
0,245  0,055  Antiarrhythmic
0,198  0,009  Keratolytic
0,215  0,029  Insulin secretagoues
0,214  0,032  UGT2B9 substrate
0,212  0,031  Antineoplastic (bone cancer)
0,234  0,054  DNA methyltransferase I inhibitor
0,199  0,022  Retinoprotector
0,284  0,110  Antiprotozoal (Plasmodium)
0,215  0,043  UGT1A3 substrate
0,210  0,043  Antiviral (Herpes)
0,181  0,015  Estrogen antagonist
0,169  0,004  Na+ K+ transporting ATPase inhibitor
0,266  0,101  Antineoplastic (osteosarcoma)
0,186  0,029  Glutathione S-transferase substrate
0,169  0,014  Antithrombocytopenic
0,214  0,060  Insulin sensitizer
0,177  0,025  Antineoplastic antibiotic
0,158  0,008  Phosphodiesterase 6D inhibitor
0,205  0,056  UGT1A4 substrate
0,195  0,046  Diuretic
0,160  0,014  Estrogen receptor beta antagonist
0,150  0,005  Ca(v)3.1 blocker
0,158  0,014  Anabolic
0,226  0,083  Antiamyloidogenic
0,165  0,023  HDL-cholesterol increasing
0,144  0,004  Squalene synthetase inhibitor
0,176  0,037  DNA polymerase I inhibitor
0,187  0,048  UGT2B15 substrate
0,159  0,022  Topoisomerase II alpha inhibitor
0,144  0,006  Peroxisome proliferator-activated receptor gamma antagonist
0,186  0,049  UGT2B10 substrate
0,140  0,004  Peroxisome proliferator-activated receptor alpha antagonist
0,226  0,091  Vascular (periferal) disease treatment
0,163  0,029  Butyrylcholinesterase inhibitor
0,136  0,004  Squalene epoxidase inhibitor
0,200  0,068  CYP2B6 inhibitor
0,153  0,025  Antiinfertility, female
0,199  0,071  Non-steroidal antiinflammatory agent
0,185  0,057  Eye irritation, high
0,195  0,067  Sepsis treatment
0,215  0,088  Teratogen
0,140  0,014  Ornithine decarboxylase inhibitor
0,155  0,030  Contraceptive female
0,176  0,056  Uterine stimulant
0,167  0,050  SULT1A3 substrate
0,151  0,037  Microtubule formation inhibitor
0,125  0,011  Phosphodiesterase VI inhibitor
0,116  0,003  Pregnane X receptor antagonist
0,281  0,170  Alpha-glucosidase inhibitor
0,113  0,005  Glucose-6-phosphate translocase inhibitor
0,142  0,034  Bronchodilator
0,158  0,051  Adenylate cyclase stimulant
0,111  0,004  Vanilloid 2 antagonist
0,153  0,048  Topoisomerase II inhibitor
0,132  0,027  Actinic keratosis treatment
0,108  0,004  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,148  0,048  Antibacterial (Helicobacter pylori)
0,145  0,044  Beta amyloid protein antagonist
0,187  0,087  Pneumotoxic
0,187  0,088  DNA methylase inhibitor
0,127  0,028  UGT2B11 substrate
0,156  0,058  Movement disorders treatment
0,112  0,018  HIV-1 integrase (Strand Transfer) inhibitor
0,111  0,018  SULT1A2 substrate
0,169  0,078  Male reproductive disfunction treatment
0,109  0,018  Leukotriene antagonist
0,142  0,052  Cell adhesion inhibitor
0,120  0,031  Thioredoxin inhibitor
0,154  0,067  Cyclooxygenase inhibitor
0,173  0,086  Antieczematic atopic
0,130  0,043  Xanthine oxidase inhibitor
0,146  0,060  Psychosexual dysfunction treatment
0,180  0,096  Antimitotic
0,125  0,043  Mediator release inhibitor
0,105  0,024  HIV-1 integrase (3'-Processing) inhibitor
0,112  0,032  Antifungal (Candida)
0,166  0,087  Diabetic nephropathy treatment
0,126  0,051  SULT1A1 substrate
0,126  0,052  Topoisomerase I inhibitor
0,142  0,067  Ca2+-transporting ATPase inhibitor
0,141  0,067  Bone formation stimulant
0,141  0,068  Contraceptive
0,091  0,019  Estrogen agonist
0,243  0,172  CYP2C9 inhibitor
0,089  0,020  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,118  0,051  MAO B inhibitor
0,201  0,134  Tyrosine 3 hydroxylase inhibitor
0,101  0,036  Inducible nitric-oxide synthase inhibitor
0,141  0,080  Antimutagenic
0,108  0,047  Prolactin inhibitor
0,065  0,005  Retinoic acid receptor agonist
0,130  0,069  MAO inhibitor
0,097  0,036  Cell adhesion molecule inhibitor
0,088  0,030  Glycine receptor agonist
0,148  0,092  Interleukin 6 antagonist
0,106  0,050  Nitric-oxide synthase inhibitor
0,090  0,034  CDC25A inhibitor
0,096  0,041  Glutathione S-transferase inhibitor
0,166  0,113  Angiogenesis stimulant
0,153  0,099  Diabetic retinopathy treatment
0,093  0,040  Phosphodiesterase 4D inhibitor
0,063  0,011  Liver X receptor alpha agonist
0,114  0,063  Aldehyde dehydrogenase substrate
0,191  0,141  CYP1A2 inhibitor
0,076  0,026  Ribonucleoside-diphosphate reductase inhibitor
0,069  0,022  Postcoital contraceptive
0,064  0,018  Farnesyltransferase inhibitor
0,085  0,039  HIV-1 reverse transcriptase inhibitor
0,176  0,130  Antipyretic
0,208  0,163  CYP3A4 inhibitor
0,074  0,029  Ribonucleotide reductase inhibitor
0,122  0,077  Cyclooxygenase 2 inhibitor
0,121  0,077  Acetylcholinesterase inhibitor
0,051  0,007  HMG CoA reductase inhibitor
0,099  0,058  DNA directed RNA polymerase inhibitor
0,119  0,080  Tubulin antagonist
0,057  0,018  Estrogen receptor beta agonist
0,118  0,081  Gastritis treatment
0,052  0,015  TRPM8 blocker
0,068  0,032  Androgen agonist
0,055  0,023  Aldosterone antagonist
0,048  0,016  Retinoic acid alpha receptor agonist
0,062  0,031  Lipocortins synthesis agonist
0,200  0,169  Angiogenesis inhibitor
0,083  0,052  Glycine receptor antagonist
0,053  0,024  Microtubule stabilization
0,090  0,062  SULT1E1 substrate
0,101  0,073  Antihypermotility
0,099  0,072  UGT2B1 substrate
0,046  0,019  Estrogen receptor alpha agonist
0,044  0,018  Retinoid X receptor antagonist
0,065  0,040  Nitric oxide donor
0,057  0,033  Thromboxane synthase inhibitor
0,090  0,067  Antischistosomal
0,155  0,133  Histone acetyltransferase inhibitor
0,062  0,040  Aromatase inhibitor
0,209  0,189  Ulceration
0,140  0,121  Lipocortins synthesis antagonist
0,167  0,148  DNA damaging
0,174  0,155  Respiratory analeptic
0,037  0,019  Retinoid X alpha receptor antagonist
0,068  0,050  HIV-1 integrase inhibitor
0,039  0,021  Nicotinic acid receptor agonist
0,115  0,098  Histone deacetylase SIRT1 inhibitor
0,067  0,052  SULT2A1 substrate
0,070  0,056  Antibiotic
0,038  0,023  Retinoid X receptor agonist
0,132  0,118  Dual specificity phosphatase inhibitor
0,088  0,074  Anticataract
0,052  0,041  Postmenopausal disorders treatment
0,125  0,114  Antifungal (Cryptococcus)
0,054  0,044  Beta tubulin antagonist
0,030  0,020  Thiazolidinedione
0,019  0,012  Retinoic acid receptor antagonist
0,099  0,092  Photosensitizer
0,126  0,120  Interferon gamma antagonist
0,082  0,078  MAO A inhibitor
0,040  0,036  Geranyltranstransferase inhibitor
0,180  0,179  Gastrin inhibitor
0,030  0,030  Retinoid X alpha receptor agonist

